LuZ, XuJ, XuM, et al.: Truncated mu-opioid receptors with 6 transmembrane domains are essential for opioid analgesia. Anesth Analg, 2018; 126:1050–1057.
6.
DavisMP, FernandezC, RegelS, McPhersonML.: Does nalbuphine have a niche in managing pain?. J Opioid Manag, 2018; 14:143–151.
7.
LoMW, ScharyWL, WhitneyCCJr: The disposition and bioavailability of intravenous and oral nalbuphine in healthy volunteers. J Clin Pharmacol, 1987; 27:866–873.
8.
LoMW, LeeFH, ScharyWL, WhitneyCC Jr: The pharmacokinetics of intravenous, intramuscular, and subcutaneous nalbuphine in healthy subjects. Eur J Clin Pharmacol, 1987; 33:297–301.
9.
ZengZ, LuJ, ShuC, ChenY, et al.: A comparision of nalbuphine with morphine for analgesic effects and safety: Meta-analysis of randomized controlled trials. Sci Rep, 2015; 5:10927.
10.
HammondJE: Reversal of opioid-associated late-onset respiratory depression by nalbuphine hydrochloride. Lancet, 1984; 2:1208.
11.
LataschL, ProbstS, DudziakR: Reversal by nalbuphine of respiratory depression caused by fentanyl. Anesth Analg, 1984; 63:814–816.
12.
LakeCL, DuckworthEN, DiFazioCA, MagruderMR: Cardiorespiratory effects of nalbuphine and morphine premedication in adult cardiac surgical patients. Acta Anaesthesiol Scand, 1984; 28:305–309.
13.
PughGC, BrownDT, DrummondGB: Effect of nalbuphine hydrochloride on the ventilatory and occlusion pressure responses to carbon dioxide in volunteers. Br J Anaesth, 1989; 62:601–609.
14.
RosowCE: The clinical usefulness of agonist-antagonist analgesics in acute pain. Drug Alcohol Depend, 1987; 20:329–337.
15.
LakeCL, DuckworthEN, DiFazioCA, DurbinCG, MagruderMR: Cardiovascular effects of nalbuphine in patients with coronary or valvular heart disease. Anesthesiology, 1982; 57:498–503.
16.
HawiA, AlcornHJr, BergJ, et al.: Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus. BMC Nephrol, 2015; 16:47.
17.
OkunR: Analgesic effects of oral nalbuphine and codeine in patients with postoperative pain. Clin Pharmacol Ther, 1982; 32:517–524.
18.
BeaverWT, FeiseGA, RobbD: Analgesic effect of intramuscular and oral nalbuphine in postoperative pain. Clin Pharmacol Ther, 1981; 29:174–180.
19.
SchnabelA, ReichlSU, ZahnPK, Pogatzki-ZahnE: Nalbuphine for postoperative pain treatment in children. Cochrane Database Syst Rev, 2014:CD009583.
